Hyperfine Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 2.53, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Hyperfine Inc in Jun 30 2026 quarter, has decreased to 144 days, compared to 168 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 502 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3333, from overall ranking in the first quarter 2026 at 4001.

What is Receivable Turnover Ratio?
What is Hyperfine Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HYPR Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-16.69 %	-20.23 %	-21.47 %	-30.39 %	-7.21 %
Y / Y Revenue Change	67.7 %	58.2 %	48.82 %	-2.06 %	-16.95 %
Receivable Turnover Ratio (TTM)	2.53	2.17	1.89	1.51	1.39
HYPR's Total Ranking	# 3333	# 4001	# 3506	# 3551	# 3597
Accounts Receivable average collection period days	144	169	194	242	263
Seq. Receivable Change	-0.14 %	-11.12 %	3.38 %	-9.21 %	-4.38 %
Seq. Revenue Change	31.05 %	-47.68 %	99.93 %	22.34 %	23.63 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 175
Healthcare Sector	# 503
Overall Market	# 3333

Receivable Turnover Ratio Statistics
High	Average	Low
3.17	2.12	1.39
(Sep 30 2022)		(Jun 30 2025)

HYPR Company Profile • Back to HYPR Efficiency Comparisons • Compare HYPR Receivables Turnover Ratio to its Competitors

Financial Statements
Hyperfine Inc 's Accounts Receivable	$ 6 Millions	Visit HYPR's Balance sheet
Hyperfine Inc 's Sales TTM	$ 15 Millions	Visit HYPR's Income Statement
Sources of HYPR's Revenues		Visit HYPR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HYPR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HYPR's Growth Rates	HYPR's Roa	HYPR's Inventory Turnover Ratio	HYPR's Dividend Comparisons
HYPR's Profitability Ratios	HYPR's Roi	HYPR's Asset Turnover Ratio	HYPR's Dividend Growth
HYPR's Valuation Ratios	HYPR's Roe	HYPR's Financial Strength Ratios	HYPR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions
Si bone inc	7.23	$ 214.331 Millions	$ 29.648 Millions
Safe Pro Group Inc	7.23	$ 2.881 Millions	$ 0.399 Millions
Insmed Inc	7.18	$ 1,076.572 Millions	$ 149.999 Millions
Rhythm Pharmaceuticals Inc	7.18	$ 239.918 Millions	$ 33.429 Millions
Travere Therapeutics Inc	7.10	$ 591.330 Millions	$ 83.339 Millions
Angiodynamics Inc	7.08	$ 317.726 Millions	$ 44.853 Millions
Pulmonx Corporation	7.07	$ 87.393 Millions	$ 12.356 Millions
Arcturus Therapeutics Holdings Inc	7.05	$ 29.368 Millions	$ 4.168 Millions
Tandem Diabetes Care Inc	6.98	$ 1,037.302 Millions	$ 148.542 Millions
Sutro Biopharma Inc	6.98	$ 45.702 Millions	$ 6.545 Millions
Edwards Lifesciences Corporation	6.98	$ 6,512.500 Millions	$ 933.400 Millions
Beyond Air Inc	6.98	$ 6.677 Millions	$ 0.957 Millions
Quidelortho Corp	6.92	$ 2,674.200 Millions	$ 386.400 Millions
Myriad Genetics Inc	6.91	$ 805.900 Millions	$ 116.650 Millions
Ceribell Inc	6.90	$ 101.804 Millions	$ 14.749 Millions
Stryker Corp	6.89	$ 25,837.000 Millions	$ 3,749.000 Millions
Nephros Inc	6.83	$ 21.686 Millions	$ 3.173 Millions
Medpace Holdings Inc	6.82	$ 2,782.288 Millions	$ 408.189 Millions
Opko Health Inc	6.79	$ 587.896 Millions	$ 86.589 Millions
Atara Biotherapeutics Inc	6.79	$ 6.452 Millions	$ 0.950 Millions
Rapid Micro Biosystems Inc	6.76	$ 34.545 Millions	$ 5.111 Millions
Universal Health Services Inc	6.75	$ 18,114.487 Millions	$ 2,683.492 Millions
Delcath Systems Inc	6.73	$ 94.058 Millions	$ 13.981 Millions
3m Company	6.72	$ 25,180.000 Millions	$ 3,747.750 Millions
Phibro Animal Health Corporation	6.70	$ 1,516.861 Millions	$ 226.555 Millions
Envista Holdings Corporation	6.69	$ 2,856.400 Millions	$ 427.250 Millions
Solventum Corporation	6.69	$ 8,310.000 Millions	$ 1,243.000 Millions
Eton Pharmaceuticals Inc	6.67	$ 105.279 Millions	$ 15.783 Millions
Neuropace Inc	6.65	$ 98.620 Millions	$ 14.834 Millions

Date modified: 2026-09-08T01:18:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.